Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

HHS had argued that Vertex's plan to cover fertility services for some patients that took its gene therapy would violate anti-kickback and inducement laws.

In a report released today, William Pickering from Bernstein maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write ...

Google launched Vertex AI way back in 2021 as a platform ... for other publications such as the Financial Times. Ingrid covers mobile, digital media, advertising and the spaces where these intersect.

URSC is built upon various shaders from the Godot community. It would not have been possible without the work done by: If you download URSC through the editor interface, uncheck "ignore asset root" to ...

Those same rules apply to the remit of an undercover cop. Enter Deep Cover, an upcoming crime comedy in which three improv comedians are recruited by the police as undercover operatives.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...